EUVIMEDEUVIMED entdecken
Leserbrief

Effectiveness and safety of reduced‐dose secukinumab switching to risankizumab for psoriasis patients in Asian population: A case series

Chang-Yu Hsieh iD, Tsen-Fang Tsai iD

Experimental Dermatology · 2023

DOI: 10.1111/exd.14810 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Experimental Dermatology, 2023. Verfasst von Chang-Yu Hsieh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, National Taiwan University Hospital, Taipei City, Taiwan. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Psoriasis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalPsoriasisHumansAntibodies, Monoclonal, HumanizedTreatment OutcomeSeverity of Illness IndexRetrospective Studies

Stichwörter der Autor:innen

biologicspsoriasisreal-worldreduced-dosesecukinumab

Substanzen

risankizumabsecukinumabAntibodies, MonoclonalAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Dermatology, National Taiwan University Hospital, Taipei City, Taiwan.

ORCID-Profile: Chang-Yu Hsieh, Tsen-Fang Tsai

Zitieren

APA

Hsieh, C. Y., & Tsai, T. F. (2023). Effectiveness and safety of reduced‐dose secukinumab switching to risankizumab for psoriasis patients in Asian population: A case series. Experimental Dermatology. https://doi.org/10.1111/exd.14810

Vancouver

Hsieh CY, Tsai TF. Effectiveness and safety of reduced‐dose secukinumab switching to risankizumab for psoriasis patients in Asian population: A case series. Experimental Dermatology. 2023. doi:10.1111/exd.14810

BibTeX
@article{Hsieh2023,
  author = {Hsieh, Chang-Yu and Tsai, Tsen-Fang},
  title = {Effectiveness and safety of reduced‐dose secukinumab switching to risankizumab for psoriasis patients in Asian population: A case series},
  journal = {Experimental Dermatology},
  year = {2023},
  doi = {10.1111/exd.14810}
}
Kostenlos starten →